Leverage Phytoform's AI and protoplast-based high-throughput assays to evaluate and validate regulatory DNA sequences efficiently. This scalable solution enables in silico predictions and in vivo validations, fostering novel plant promoter discoveries.
Phytoform Labs offers an advanced solution for evaluating gene expression through a combination of AI-driven genomic modeling and high-throughput protoplast assays. This innovative approach allows for scalable evaluation of regulatory DNA sequences, offering both in silico predictions and in vivo validations. By leveraging a sequence-to-function genomic model trained on extensive multi-species genomic data, alongside a protoplast-based massively parallel reporter assay (MPRA), Phytoform enables efficient discovery of novel plant promoter variants.
The core technology involves a sequence-to-function (S2F) genomic model trained on 12 species reference genomes and over 5,000 RNA-seq coverage tracks. This model predicts gene expression profiles from 65kb genomic sequences. Complementarily, the protoplast-based MPRA quantitatively validates thousands of gene sequences simultaneously, associating RNA-barcodes with DNA regulatory variants using the MPRAflow pipeline. The model's effectiveness is demonstrated by a high gene level correlation and conditional correlation, validated through custom assays and fluorescence-based transient expression assays.
Currently, the technology is at TRL 4, having been validated under laboratory conditions with both computational and experimental methods. The next steps involve promoter evolution campaigns and adjusting project plans to focus on specific needs, such as screening existing promoter variants.
Founded in 2017, Phytoform is a gene-editing startup focusing on sustainable crop traits. It has received grants and seed funding in the UK and gained attention for its innovative use of AI in plant genomics, targeting improvements in yield and defense without transgenics.